KELL BLOOD GROUP SYSTEM
Tracking # 20-1272005
Course overview
THE KELL BLOOD GROUP SYSTEM IS A COLLECTION OF ANTIGENS FOUND ON RED BLOOD CELLS, ERYTHROID CELLS, MYELOID PROGENITOR CELLS, AND OTHER TISSUES. THESE ANTIGENS ARE HIGHLY IMMUNOGENIC, FOLLOWING ONLY THE ABO AND RHESUS D SYSTEMS IN SIGNIFICANCE. THE KELL SYSTEM’S ANTIGENS, FULLY DEVELOPED AT BIRTH, CAN PROVOKE STRONG IMMUNE RESPONSES IN TRANSFUSIONS AND ARE IMPLICATED IN HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, AS WELL AS MCLEOD SYNDROME. THE KELL ANTIGENS ARE DETECTED ON FETAL ERYTHROCYTES AS EARLY AS 10 WEEKS GESTATION, HIGHLIGHTING THE IMPORTANCE OF EARLY RECOGNITION AND MANAGEMENT IN PREGNANCY AND TRANSFUSION MEDICINE.IN THIS COURSE, PARTICIPANTS GAIN AN UNDERSTANDING OF THE FUNCTIONAL AND CLINICAL ROLE OF THE KELL BLOOD GROUP SYSTEM, INCLUDING ITS SIGNIFICANCE IN TRANSFUSION REACTIONS AND FETAL COMPLICATIONS. CLINICIANS AND NURSES LEARN TO RECOGNIZE HOW IMMUNOHISTOLOGICAL REACTIVITIES OF THE KELL SYSTEM INFLUENCE CLINICAL OUTCOMES AND BECOME PROFICIENT IN INTERPRETING LABORATORY RESULTS RELATED TO THESE ANTIGENS. COLLABORATION WITH AN INTERPROFESSIONAL TEAM, INCLUDING HEMATOLOGISTS, OBSTETRICIANS, AND LABORATORY TECHNOLOGISTS, IS EMPHASIZED TO IMPROVE PATIENT CARE, ENHANCE DIAGNOSTIC ACCURACY, AND MITIGATE TRANSFUSIONS AND HEMOLYTIC CONDITIONS RISKS.
Subject areas
This course counts toward the state boards and subject areas below.